DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Invizyne Technologies (NASDAQ:IZTC), Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Citius Oncology (NASDAQ:CTOR).
DBV Technologies has a consensus price target of $6.00.
The stock price for DBV Technologies (NASDAQ: DBVT) is $4.4 last updated January 17, 2025 at 4:18 PM EST.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.